Abstract
Background
MicroRNAs (miRNAs) play essential roles in the regulation and pathophysiology of various types of cancers including esophageal carcinoma (ESCA). Increasing numbers of miRNAs have been identified to be important regulators in the progression of ESCA by regulating gene expression. However, functional miRNAs and the underlying mechanisms involved in ESCA need sufficient elucidation.
Aims
In the present study, the function of miR-2053 was investigated in ESCA cells.
Methods
The expression of miR-2053 was detected in four different ESCA cell lines (Eca109, Ec9706, KYSE30, and TE-1 cells) and normal cell line (HEEC) by qRT-PCR. Cell proliferation, migration, and invasion abilities after knockdown of miR-2053 were assessed by CCK-8 assay, scratch assay, and transwell assay, respectively. Cell cycle of ESCA cells was detected by flow cytometric analysis. Expression of proteins in ESCA cells was detected by Western blot analysis.
Results
The results showed that the expression of miR-2053 was remarkably up-regulated in ESCA tissues and cells lines. Down-regulation of miR-2053 markedly inhibited cell proliferation, migration, and invasion and markedly induced cell cycle arrest and cell apoptosis in ESCA cell lines. Fyn-related kinase (FRK) was a target gene of miR-2053. Moreover, down-regulation of miR-2053 mediated the protein kinase B (AKT)/mammalian target of rapamycin and Wnt3a/β-catenin signaling pathway in ESCA cell lines.
Conclusions
Our results together suggest the potential of regulating miR-2053 expression against development and progression of esophageal carcinoma by targeting FRK.
Similar content being viewed by others
References
Fitzmaurice C, Akinyemiju TF, Al Lami FH, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2016: a systematic analysis for the global burden of disease study. JAMA Oncol. 2018;4:1553–1568.
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66:7–30. https://doi.org/10.3322/caac.21332.
Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–E386. https://doi.org/10.1002/ijc.29210.
Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136:215–233.
Bentwich I, Avniel A, Karov Y, et al. Identification of hundreds of conserved and nonconserved human microRNAs. Nat Genet. 2005;37:766–770.
Berezikov E, Guryev V, van de Belt J, Wienholds E, Plasterk RHA, Cuppen E. Phylogenetic shadowing and computational identification of human microRNA genes. Cell. 2005;120:21–24.
Osman A. MicroRNAs in health and disease–basic science and clinical applications. Clin Lab. 2012;58:393–402.
Anadol E, Schierwagen R, Elfimova N, et al. Circulating MicroRNAs as a marker for liver injury in human immunodeficiency virus patients. Hepatology. 2015;61:46–55. https://doi.org/10.1002/hep.27369.
O’Neill LA, Sheedy FJ, McCoy CE. MicroRNAs: the fine-tuners of Toll-like receptor signalling. Nat Rev Immunol. 2011;11:163–175.
Kano M, Seki N, Kikkawa N, et al. miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma. Int J Cancer. 2010;127:2804–2814.
Wang N, Zhang C, He J, et al. MiR-21 down-regulation suppresses cell growth, invasion and induces cell apoptosis by targeting FASL, TIMP3, and RECK genes in esophageal carcinoma. Dig Dis Sci. 2013;58:1863–1870. https://doi.org/10.1007/s10620-013-2612-2.
Kang M, Li Y, Liu W, et al. miR-129-2 suppresses proliferation and migration of esophageal carcinoma cells through downregulation of SOX4 expression. Int J Mol Med. 2013;32:51–58.
Parsons SJ, Parsons JT. Src family kinases, key regulators of signal transduction. Oncogene. 2004;23:7906.
Wheeler DL, Iida M, Dunn EF. The role of Src in solid tumors. Oncologist. 2009;14:667–678.
Cance WG, Craven RJ, Bergman M, Xu L, Alitalo K, Liu ET. Rak, a novel nuclear tyrosine kinase expressed in epithelial cells. Cell Growth Differ. 1994;5:1347–1356.
Annerén C, Lindholm CK, Kriz V, Welsh M. The FRK/RAK-SHB signaling cascade: a versatile signal-transduction pathway that regulates cell survival, differentiation and proliferation. Curr Mol Med. 2003;3:313–324.
Meyer T, Xu L, Chang J, Liu ET, Craven RJ, Cance WG. Breast cancer cell line proliferation blocked by the Src-related Rak tyrosine kinase. Int J Cancer. 2003;104:139–146.
Yim E-K, Peng G, Dai H, et al. Rak functions as a tumor suppressor by regulating PTEN protein stability and function. Cancer Cell. 2009;15:304–314.
Wu S, Lin Y, Xu D, et al. MiR-135a functions as a selective killer of malignant glioma. Oncogene. 2012;31:3866.
Yuan D, Xu J, Wang J, et al. Extracellular miR-1246 promotes lung cancer cell proliferation and enhances radioresistance by directly targeting DR5. Oncotarget. 2016;7:32707.
Lee K-H, Goan Y-G, Hsiao M, et al. MicroRNA-373 (miR-373) post-transcriptionally regulates large tumor suppressor, homolog 2 (LATS2) and stimulates proliferation in human esophageal cancer. Exp Cell Res. 2009;315:2529–2538.
Zhan C, Yan L, Wang L, et al. Landscape of expression profiles in esophageal carcinoma by The Cancer Genome Atlas data. Dis Esophagus. 2016;29:920–928.
Zhao J, Wang F, Li Y, et al. Five miRNAs considered as molecular targets for predicting esophageal cancer. Med Sci Monit Int Med J Exp Clin Res. 2015;21:3222.
Ogawa R, Ishiguro H, Kuwabara Y, et al. Expression profiling of micro-RNAs in human esophageal squamous cell carcinoma using RT-PCR. Med Mol Morphol. 2009;42:102.
Zeng J-H, Xiong D-D, Pang Y-Y, et al. Identification of molecular targets for esophageal carcinoma diagnosis using miRNA-seq and RNA-seq data from The Cancer Genome Atlas: a study of 187 cases. Oncotarget. 2017;8:35681.
Chandrasekharan S, Qiu TH, Alkharouf N, Brantley K, Mitchell JB, Liu ET. Characterization of mice deficient in the Src family nonreceptor tyrosine kinase Frk/rak. Mol Cell Biol. 2002;22:5235–5247.
Yim E-K, Siwko S, Lin S-Y. Exploring Rak tyrosine kinase function in breast cancer. Cell Cycle. 2009;8:2360–2364.
Zhou X, Hua L, Zhang W, et al. FRK controls migration and invasion of human glioma cells by regulating JNK/c-Jun signaling. J Neurooncol. 2012;110:9–19.
Varnholt H, Drebber U, Schulze F, et al. MicroRNA gene expression profile of hepatitis C virus–associated hepatocellular carcinoma. Hepatology. 2008;47:1223–1232.
Fernando R, Foster JS, Bible A, et al. Breast cancer cell proliferation is inhibited by Bad regulation of Cyclin D1. J Biol Chem. 2007;282:28864–28873.
Huang X, Dai C, Mou Z, et al. Overproduction of cyclin D1 is dependent on activated mTORC1 signal in nasopharyngeal carcinoma: implication for therapy. Cancer Lett. 2009;279:47–56.
Lamouille S, Derynck R. Cell size and invasion in TGF-$β$–induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathway. J Cell Biol. 2007;178:437–451.
Surviladze Z, Sterk RT, DeHaro SA, Ozbun MA. Cellular entry of human papillomavirus type 16 involves activation of the phosphatidylinositol 3-kinase/Akt/mTOR pathway and inhibition of autophagy. J Virol. 2013;87:2508–2517.
Zhang L, Wu J, Ling MT, Zhao L, Zhao K-N. The role of the PI3K/Akt/mTOR signalling pathway in human cancers induced by infection with human papillomaviruses. Mol Cancer. 2015;14:87.
Bastos LGDR, de Marcondes PG, de-Freitas-Junior JCM, et al. Progeny from irradiated colorectal cancer cells acquire an EMT-like phenotype and activate Wnt/$β$-catenin pathway. J Cell Biochem. 2014;115:2175–2187.
Liang J, Liang L, Ouyang K, Li Z, Yi X. MALAT 1 induces tongue cancer cells’ EMT and inhibits apoptosis through Wnt/$β$-catenin signaling pathway. J Oral Pathol Med. 2017;46:98–105.
Nieto MA. The ins and outs of the epithelial to mesenchymal transition in health and disease. Annu Rev Cell Dev Biol. 2011;27:347–376.
Polyak K, Weinberg RA. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer. 2009;9:265.
Stappert J, Kemler R. A short core region of E-cadherin is essential for catenin binding and is highly phosphorylated. Cell Adhes Commun. 1994;2:319–327.
Joo Y-E, Rew J-S, Choi S-K, Bom H-S, Park C-S, Kim S-J. Expression of E-cadherin and catenins in early gastric cancer. J Clin Gastroenterol. 2002;35:35–42.
Nguyen PT, Kudo Y, Yoshida M, Kamata N, Ogawa I, Takata T. N-cadherin expression is involved in malignant behavior of head and neck cancer in relation to epithelial-mesenchymal transition. Histol Histopathol. 2011;26:147.
Funding
Not applicable.
Author information
Authors and Affiliations
Contributions
YZ was involved in supervision, concept, and analysis; BW, LZ, JL, and PH were involved in data collection and analysis; all authors participated in the manuscript preparation.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests.
Ethics approval and consent to participate
The present study was approved by the Ethics Committee of the Second Hospital of Jilin University. The research has been carried out in accordance with the World Medical Association Declaration of Helsinki. All patients and healthy volunteers provided written informed consent prior to their inclusion within the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Wang, B., Zhang, L., Li, J. et al. Down-Regulation of miR-2053 Inhibits the Development and Progression of Esophageal Carcinoma by Targeting Fyn-Related Kinase (FRK). Dig Dis Sci 65, 2853–2862 (2020). https://doi.org/10.1007/s10620-019-06015-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-019-06015-5